Format

Send to

Choose Destination
J Invest Dermatol. 2014 Jun;134(6):1675-1685. doi: 10.1038/jid.2014.20. Epub 2014 Jan 17.

TGF-β-induced (TGFBI) protein in melanoma: a signature of high metastatic potential.

Author information

1
Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France.
2
INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France.
3
Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Pharmacology-Genetics Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France.
4
Dermatology Department, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 976, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France.
5
Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France; Jean Dausset Laboratory, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France.
6
Centre de Recherche du CHU de Québec, Université Laval, Québec, Canada.
7
INSERM UMR 1043 and CNRS UMR 5282, University Toulouse III Paul Sabatier, Toulouse, France. Electronic address: nabila.jabrane-ferrat@inserm.fr.
8
Institut National de la Santé et de la Recherche Médicale (INSERM) UMRS 940, University Paris 7-Denis Diderot, AP-HP, Saint Louis Hospital, Paris, France. Electronic address: reem.al-daccak@inserm.fr.

Abstract

Tumor-produced extracellular matrix (ECM) proteins can be key elements in tumor growth and metastasis. Transforming growth factor beta-inducible (TGFBI) protein is a secreted ECM component that can have dual function in cancer, acting as tumor suppressor or promoter. Although TGFBI is expressed in human melanoma cells, the exact role it might have in melanoma metastasis remains elusive. Assessing the expression and secretion of TGFBI, we show that human metastatic melanomas express and secrete significantly higher amounts of TGFBI, compared with nevus lesions and primary melanoma tumors. Intravenous injection of highly metastatic human melanoma cells expressing shRNA that targets TGFBI assigns a critical role for TGFBI in the formation of melanoma distal metastases in nude mice. In vivo assays demonstrate that TGFBI silencing does not interfere with melanoma cells' dissemination to distal sites but rather with their proliferation and outgrowth within new microenvironment. In line, TGFBI silencing increases melanoma cells motility/invasion/extravasation in vitro but interferes with their progression through the cell cycle, drastically reducing their proliferation. Furthermore, we show that TGFBI is a regulator of cyclins and cyclin-dependent kinases in melanoma. Collectively, our data describe a mechanism of melanoma metastatic outgrowth via promotion of growth/survival by the ECM protein TGFBI.

PMID:
24499734
DOI:
10.1038/jid.2014.20
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center